<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37398664</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Risk and Factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients.</ArticleTitle><Pagination><StartPage>1200732</StartPage><MedlinePgn>1200732</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1200732</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1200732</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Lupus nephritis (LN) remains one of the most severe manifestations in patients with systemic lupus erythematosus (SLE). Onset and overall LN risk among SLE patients remains considerably difficult to predict. Utilizing a territory-wide longitudinal cohort of over 10 years serial follow-up data, we developed and validated a risk stratification strategy to predict LN risk among Chinese SLE patients - Risk and Factors associated with disease manifestations in systemic Lupus Erythematosus - Lupus Nephritis (RIFLE-LN).</AbstractText><AbstractText Label="METHODS">Demographic and longitudinal data including autoantibody profiles, clinical manifestations, major organ involvement, LN biopsy results and outcomes were documented. Association analysis was performed to identify factors associated with LN. Regression modelling was used to develop a prediction model for 10-year risk of LN and thereafter validated.</AbstractText><AbstractText Label="RESULTS">A total of 1652 patients were recruited: 1382 patients were assigned for training and validation of the RIFLE-LN model; while 270 were assigned for testing. The median follow-up duration was 21 years. In the training and validation cohort, 845 (61%) of SLE patients developed LN. Cox regression and log rank test showed significant positive association between male sex, age of SLE onset and anti-dsDNA positivity. These factors were thereafter used to develop RIFLE-LN. The algorithm was tested in 270 independent patients and showed good performance (AUC = 0&#xb7;70).</AbstractText><AbstractText Label="CONCLUSION">By using male sex, anti-dsDNA positivity, age of SLE onset and SLE duration; RIFLE-LN can predict LN among Chinese SLE patients with good performance. We advocate its potential utility in guiding clinical management and disease monitoring. Further validation studies in independent cohorts are required.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Chan, Wang, Yap, Chan, Lau, Lee, Lai, Ying, Tse, Leung, Mok, Lee, Li, Tsang, Yeung, Ho, Wong, Yang, Lau and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Shirley C W</ForeName><Initials>SCW</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yong-Fei</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Paediatrics &amp; Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life and Health Sciences, School of Medicine and Warshel Institute for Computational Biology, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>Desmond Y H</ForeName><Initials>DYH</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Tak Mao</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Yu Lung</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Paediatrics &amp; Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Pamela P W</ForeName><Initials>PPW</Initials><AffiliationInfo><Affiliation>Department of Paediatrics &amp; Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Wai Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Department of Paediatrics &amp; Adolescent Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Shirley K Y</ForeName><Initials>SKY</Initials><AffiliationInfo><Affiliation>Department of Medicine &amp; Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Niko K C</ForeName><Initials>NKC</Initials><AffiliationInfo><Affiliation>Department of Paediatrics &amp; Adolescent Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Alexander M H</ForeName><Initials>AMH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mok</LastName><ForeName>Chi Chiu</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ka Lai</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Teresa W L</ForeName><Initials>TWL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Helen H L</ForeName><Initials>HHL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Winnie W Y</ForeName><Initials>WWY</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Carmen T K</ForeName><Initials>CTK</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Raymond W S</ForeName><Initials>RWS</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wanling</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Paediatrics &amp; Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Chak Sing</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Philip H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">lupus nephritis</Keyword><Keyword MajorTopicYN="N">model</Keyword><Keyword MajorTopicYN="N">prediction</Keyword><Keyword MajorTopicYN="N">risk assessment</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>11</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37398664</ArticleId><ArticleId IdType="pmc">PMC10311203</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1200732</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. . European League against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (2019) 71(9):1400&#x2013;12. doi: 10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 40(9):1725. doi: 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. . Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 64(8):2677&#x2013;86. doi: 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PH, Wong WH, Lee TL, Lau CS, Chan TM, Leung AMH, et al. . Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatol (Oxford) (2013) 52(2):337&#x2013;45. doi: 10.1093/rheumatology/kes261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kes261</ArticleId><ArticleId IdType="pubmed">23038697</ArticleId></ArticleIdList></Reference><Reference><Citation>To CH, Mok CC, Tang SS, Ying SK, Wong RW, Lau CS. Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis. Lupus (2009) 18(14):1267&#x2013;75. doi: 10.1177/0961203309345767</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345767</ArticleId><ArticleId IdType="pubmed">19861343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. . Systemic lupus erythematosus. Nat Rev Dis Primers (2016) 2:16039. doi: 10.1038/nrdp.2016.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol (2017) 12(5):825&#x2013;35. doi: 10.2215/CJN.05780616</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05780616</ArticleId><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. . Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. the European working party on systemic lupus erythematosus. Med (Baltimore) (1993) 72(2):113&#x2013;24. doi: 10.1097/00005792-199303000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-199303000-00005</ArticleId><ArticleId IdType="pubmed">8479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol (2016) 68(6):1432&#x2013;41. doi: 10.1002/art.39594</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39594</ArticleId><ArticleId IdType="pmc">PMC5071782</ArticleId><ArticleId IdType="pubmed">26815601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenderfer SE, Ruth NM, Brunner HI. Advances in the care of children with lupus nephritis. Pediatr Res (2017) 81(3):406&#x2013;14. doi: 10.1038/pr.2016.247</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2016.247</ArticleId><ArticleId IdType="pubmed">27855151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez Sepulveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jonsen A, et al. . Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ (2019) 10(1):60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6915972</ArticleId><ArticleId IdType="pubmed">31843005</ArticleId></ArticleIdList></Reference><Reference><Citation>Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med (2002) 112(9):726&#x2013;9. doi: 10.1016/S0002-9343(02)01118-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(02)01118-X</ArticleId><ArticleId IdType="pubmed">12079714</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agostino RB, Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. . General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation (2008) 117(6):743&#x2013;53. doi: 10.1161/CIRCULATIONAHA.107.699579</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.699579</ArticleId><ArticleId IdType="pubmed">18212285</ArticleId></ArticleIdList></Reference><Reference><Citation>Candido Dos Reis FJ, Wishart GC, Dicks EM, Greenberg D, Rashbass J, Schmidt M, et al. . An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Res (2017) 19(1):58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5440946</ArticleId><ArticleId IdType="pubmed">28532503</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamichou C, Genitsaridi I, Nikolopoulos D, Nikoloudaki M, Repa A, Bortoluzzi A, et al. . Lupus or not? SLE risk probability index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Ann Rheum Dis (2021) 80(6):758&#x2013;66. doi: 10.1136/annrheumdis-2020-219069</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219069</ArticleId><ArticleId IdType="pmc">PMC8142436</ArticleId><ArticleId IdType="pubmed">33568388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al. . Revision of the international society of Nephrology/Renal pathology society classification for lupus nephritis: clarification of definitions, and modified national institutes of health activity and chronicity indices. Kidney Int (2018) 93(4):789&#x2013;96. doi: 10.1016/j.kint.2017.11.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2017.11.023</ArticleId><ArticleId IdType="pubmed">29459092</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. . Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int (2005) 67(6):2089&#x2013;100. doi: 10.1111/j.1523-1755.2005.00365.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00365.x</ArticleId><ArticleId IdType="pubmed">15882252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Kwok RC, Yip PS. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum (2013) 65(8):2154&#x2013;60. doi: 10.1002/art.38006</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38006</ArticleId><ArticleId IdType="pubmed">23754671</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DY, Yung S, Chan TM. Lupus nephritis: an update on treatments and pathogenesis. Nephrol (Carlton) (2018) 23(Suppl 4):80&#x2013;3. doi: 10.1111/nep.13469</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13469</ArticleId><ArticleId IdType="pubmed">30298658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA, et al. . Differences in disease phenotype and severity in SLE across age groups. Lupus (2016) 25(14):1542&#x2013;50. doi: 10.1177/0961203316644333</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316644333</ArticleId><ArticleId IdType="pmc">PMC5089221</ArticleId><ArticleId IdType="pubmed">27147622</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M. Sex hormones and systemic lupus erythematosus. Lupus (2008) 17(5):412&#x2013;5. doi: 10.1177/0961203308090026</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308090026</ArticleId><ArticleId IdType="pubmed">18490418</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekvig OP. The dsDNA, anti-dsDNA antibody, and lupus nephritis: what we agree on, what must be done, and what the best strategy forward could be. Front Immunol (2019) 10:1104. doi: 10.3389/fimmu.2019.01104</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01104</ArticleId><ArticleId IdType="pmc">PMC6529578</ArticleId><ArticleId IdType="pubmed">31156647</ArticleId></ArticleIdList></Reference><Reference><Citation>Delfino J, Dos Santos T, Skare TL. Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center. Adv Rheumatol (2020) 60(1):5. doi: 10.1186/s42358-019-0105-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-019-0105-5</ArticleId><ArticleId IdType="pubmed">31900216</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J (2019) 6(2):94&#x2013;8. doi: 10.7861/futurehosp.6-2-94</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/futurehosp.6-2-94</ArticleId><ArticleId IdType="pmc">PMC6616181</ArticleId><ArticleId IdType="pubmed">31363513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat BioMed Eng (2018) 2(10):719&#x2013;31. doi: 10.1038/s41551-018-0305-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-018-0305-z</ArticleId><ArticleId IdType="pubmed">31015651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Zhang Y, Lin Z, Zhang H, Wang TY, Cao Y, et al. . Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun (2021) 12(1):772. doi: 10.1038/s41467-021-21049-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21049-y</ArticleId><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Kim K, Suetsugu H, Bang SY, Wen L, Koido M, et al. . Meta-analysis of 208370 East asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann Rheum Dis (2021) 80(5):632&#x2013;40. doi: 10.1136/annrheumdis-2020-219209</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219209</ArticleId><ArticleId IdType="pmc">PMC8053352</ArticleId><ArticleId IdType="pubmed">33272962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wang YF, Zhang Y, Lin Z, Cao Y, Zhang H, et al. . Independent replication on genome-wide association study signals identifies IRF3 as a novel locus for systemic lupus erythematosus. Front Genet (2020) 11:600. doi: 10.3389/fgene.2020.00600</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00600</ArticleId><ArticleId IdType="pmc">PMC7348047</ArticleId><ArticleId IdType="pubmed">32719713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>